Maternal obesity associated with increased risk of perinatal ischemic stroke
1. There is a dose-response relationship between maternal body mass index (BMI) and perinatal ischemic stroke (PIS) risk Evidence Rating ...
Tag: obesity
Prevalence of common chronic conditions in Medicare Advantage and traditional Medicare beneficiaries
1. In this cross-sectional study, Medicare Advantage (MA) beneficiaries had a similar prevalence of obesity, hypertension, hyperlipidemia, and chronic kidney ...
Glucagon-like peptide-1 receptor agonists associated with lower depression risk in older adults with diabetes
1. In this target trial emulation, glucagon-like peptide-1 receptor agonists (GLP-1RAs) were associated with a lower risk of depression compared ...
High flow nasal cannula reduces hypoxia for obese patients undergoing endoscopy
1. The use of high flow nasal cannula (HFNC) in patients with obesity undergoing sedated gastrointestinal endoscopy significantly reduced the ...
Roux-en-Y gastric bypass and sleeve gastrectomy may be equally cost-effective among patients with type 2 diabetes
1. In this retrospective cohort study of patients with diabetes who received Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy, health ...
![Active smoking cessation intervention may provide tangible results [Project CLIQ]](https://www.2minutemedicine.com/wp-content/uploads/2014/12/smoking-e1418644951268-350x250.jpg)
Semaglutide may aid tobacco cessation in patients with comorbid diabetes
1. In this retrospective study of patients with comorbid type 2 diabetes mellitus and tobacco use disorder (TUD), semaglutide use ...
Glucagon-like peptide-1 receptor agonists and co-agonists safe and effective for weight loss
1. In this systematic review, glucagon-like peptide-1 receptor agonists and co-agonists were effective in inducing weight loss in overweight adults ...
Roles of low muscle strength and sarcopenic obesity on incident symptomatic knee osteoarthritis
1. Low muscle strength, obesity, and sarcopenic obesity were associated with a greater risk of incident symptomatic knee osteoarthritis (OA) ...
Semaglutide reduces body weight and pain symptoms in obese patients with knee osteoarthritis
1. In this randomized controlled trial, once-weekly semaglutide led to significant weight loss compared to placebo over 68 weeks in ...
#Visual Abstract: Semaglutide Imrpoves Weight Loss Gains and Pain Related to Knee Osteoarthritis in Patients with Obesity
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...